ScienceDex / Researcher record
Rodick, Robert
- Vxbiosciences, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $2,820,494 | 1 | #1,911 |
| 2023 | $2,297,089 | 2 | #2,949 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20211 record
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award records by amount
NIH award records listing Rodick, Robert as a PI. Multi-PI records show the full award amount for context.
- 3R01AI169443-01S1R01Contact PIAutonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention$2Maward amount
- 1R42AI174554-01A1R42Contact PIDevelopment of a first-in-class antiviral to address CMV drug resistance in immunocompromised patients$300Kaward amount
Award organization
Organizations that administered FY2023 awards listing Rodick, Robert as a PI.
FY2023 award administered by Vxbiosciences, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardVxbiosciences, Inc.
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #1911
- 2021Entered Top 25% NationallyRanked #1911
- 2021Entered Top 10% NationallyRanked #1911
- 2021R01 Grant Holder
- 2023$5M Cumulative Funding